← SynDRA
OLINCIGUAT
SynDRA canonical compound SYN0039710 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GUCY1A1 | GUCY1A2 |
| Mechanism of action | guanylyl cyclase activator |
| Indication | anemia |
| Disease area | hematology |
All known targets
Mechanisms of action (all sources)
- guanylyl cyclase activator
Cross-references
Synonyms
- IW-1701
- IW1701
- UNII-PD5F4ZXD21
- PD5F4ZXD21
- 5-(1,2-oxazol-3-yl)-1H-pyrazol-
- 3-yl}pyrimidin-4-yl)amino]methyl}-2-hydroxypropanamide
- (2R)-3,3,3-trifluoro-2-{[(5-fluoro-2-{1-[(2-fluorophenyl)methyl]-
- Olinciguat [INN]
- Olinciguat [USAN]
- Olinciguat (USAN/INN)
- Olinciguat [USAN:INN]
- CHEMBL4297616
- SCHEMBL16081945
- GTPL10213
- BDBM321744
- DB15238
- US10183021, Compound I-531
- AC-31551
- HY-109066
- CS-0033431
- D11475
- (2~{R})-3,3,3-trifluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]amino]methyl]-2-hydroxypropanamide
- (2R)-3,3,3-trifluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]amino]methyl]-2-hydroxypropanamide
- IW 1701
- OLINCIGUAT [WHO-DD]
- olinciguatum
- RefChem:856730
- sGC Stimulator IW-1701
- Soluble Guanylate Cyclase Stimulator IW-1701
- Stimulator of Soluble Guanylate Cyclase IW-1701
- Olinciguat (IW-1701)?
- orb1307933
- SCHEMBL29382293
- YWQFJNWMWZMXRW-HXUWFJFHSA-N
- GLXC-27236
- EX-A8369
- AKOS040742331
- DA-76407
- MS-29458
Look up OLINCIGUAT in the interactive SynDRA portal →